Form 4: BioLife Solutions CMO Todd Berard Reports Stock Withholding
Statement of Changes in Beneficial Ownership
Chief Marketing Officer Todd Berard reported the withholding of 356 shares of BioLife Solutions common stock to satisfy tax obligations.
Summary
- Reporting person Todd Berard, Chief Marketing Officer of BioLife Solutions, Inc. (BLFS), executed a transaction on June 8, 2026.
- The transaction involved the withholding of 356 shares of common stock by the issuer.
- The shares were withheld at a price of $26.10 per share.
- The purpose of the transaction was to satisfy tax withholding obligations related to the vesting of restricted stock units.
- Following this transaction, the reporting person maintains beneficial ownership of 163,412 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a mandatory tax withholding transaction rather than a discretionary trade.
Positives
- The transaction is a routine administrative action related to tax obligations upon the vesting of equity compensation, rather than a discretionary market sale.
Negatives
- None identified; this is a standard tax-related withholding event.
Risks
- None identified; this is a standard tax-related withholding event.
Future Outlook
Not applicable as this is a retrospective disclosure of a specific equity transaction.
Industry Context
StockSavvy.ai notes that routine tax withholding filings are standard practice for corporate executives and do not typically signal changes in management sentiment or company outlook.
Comparison to Industry Standards
- The transaction follows standard corporate governance practices for equity-based compensation tax compliance consistent with SEC reporting requirements for publicly traded companies.
Stakeholder Impact
- Minimal impact on shareholders as the transaction is a standard administrative process for executive compensation.
Key Dates
| Date | Description |
|---|---|
| 06/08/2026 | Date of the transaction involving the withholding of shares. |
| 06/10/2026 | Date the Form 4 was signed and filed. |
Keywords
BioLife Solutions, BLFS, Form 4, Insider Trading, Tax Withholding, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.